Congress, White House collude to roll back rules and defund safety agencies, endangering millions of workers.
President Donald Trump reportedly might reconsider his opposition to TTIP. We investigated how a trade deal with Europe could harm the health of Americans.
The Atlantic Coastal Pipeline will enrich investors, but it may permanently scar the Appalachian Trail and jeopardize the health, safety and peace of mind of the region’s most vulnerable residents.
Witnesses tell Senators that Russian disinformation intensified before the 2016 election, and has advanced Putin’s international agenda.
Journalists shed light on new challenges they face, but offer few solutions. Does White House abuse of the press reflect a lack of discipline — or something more sinister?
Pro-business lawyers, scholars dominate Hill conference pushing deregulatory agenda.
Last Friday, while the mainstream media were focused on Trump’s press secretary excluding reporters from a briefing, Trump was making real news: signing an executive order smoothing the way for cutting most federal regulations, jeopardizing public health and safety.
A bipartisan health law that was recently passed ostensibly makes it easier for patients to get access to potentially helpful new drugs. But experts warn there could be serious side effects.
With draconian budget cuts, behavior causing committed staff to leave, and the passage of laws that would make it impossible for an agency to function under any administration, are Trump and Congress trying to destroy the Environmental Protection Agency?
State Department employees appear to be losing a valuable free speech right in existence since the days of the Vietnam War under the new Trump regime. Since 1971, the agency has permitted State Department staff to express dissenting views on policies without fear of retaliation. These “dissent memos” often are taken seriously by State Department Read More
The political reporters at President-elect Donald Trump’s news conference on Jan. 11 were so focused on Russia and conflicts of interest that they missed a true nugget of news. Early into his press conference, Donald Trump said something that sent drug stocks into a tailspin, and made pharmaceutical executives cringe. He first complained that too Read More